Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.
…
continue reading
1
Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of Metastatic Breast Cancer
2:01:00
2:01:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
2:01:00
Featuring perspectives from Dr Erika Hamilton, Dr Kevin Kalinsky, Dr Ian E Krop, Dr Joyce O’Shaughnessy and Dr Sara M Tolaney, including the following topics: Introduction (0:00) Optimizing the Care of Patients with HER2-Positive Metastatic Breast Cancer (mBC) — Dr Krop (10:17) Selection and Sequencing of Therapy for Patients with Metastatic Triple…
…
continue reading
1
Chronic Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Myeloid Leukemia
1:27:00
1:27:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:27:00
Featuring perspectives from Prof Andreas Hochhaus, Dr Michael J Mauro and Dr B Douglas Smith, moderated by Dr Mauro, including the following topics: Introduction (0:00) Up-Front Therapy for Chronic Myeloid Leukemia (CML) — Prof Hochhaus (2:45) Management of Relapsed CML, Including in Patients with a T315I Mutation — Dr Mauro (29:23) Tolerability an…
…
continue reading
1
Acute Myeloid Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Acute Myeloid Leukemia
1:58:51
1:58:51
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:58:51
Featuring perspectives from Dr Alexander Perl, Dr Eytan M Stein, Dr Richard M Stone, Dr Eunice S Wang and Prof Andrew H Wei, moderated by Dr Stein, including the following topics: Introduction (0:00) Treatment for Older Patients with Acute Myeloid Leukemia (AML) — Prof Wei (2:48) Selection of Initial Therapy for Younger Patients with AML without a …
…
continue reading
1
Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Role of Endocrine-Based Therapy in the Management of Breast Cancer
2:00:37
2:00:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
2:00:37
Featuring perspectives from Dr Matthew P Goetz, Dr Sara A Hurvitz, Dr Komal Jhaveri, Dr Virginia Kaklamani and Dr Seth Wander, including the following topics: Introduction (0:00) Role of CDK4/6 Inhibitors in Hormone Receptor (HR)-Positive Localized Breast Cancer — Dr Hurvitz (12:21) Incorporation of CDK4/6 Inhibitors into the Management of HR-Posit…
…
continue reading
1
HER2-Low and HER2-Ultralow Breast Cancer | Rounds with the Investigators: Compelling Teaching Cases Focused on the Management of HER2-Low and HER2-Ultralow Breast Cancer
1:31:29
1:31:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:31:29
Featuring perspectives from Dr Aditya Bardia, Prof Giuseppe Curigliano, Dr Hope S Rugo and Dr Antonio C Wolff, including the following topics: Introduction (0:00) Optimizing the Identification of HER2-Low and HER2-Ultralow Breast Cancer — Dr Wolff (2:28) Available Data with HER2-Targeted Therapy for HER2-Low and HER2-Ultralow Disease — Dr Bardia (2…
…
continue reading
1
Multiple Myeloma | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Multiple Myeloma
1:57:11
1:57:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:57:11
Featuring perspectives from Dr Sagar Lonial, Prof Philippe Moreau, Dr Robert Z Orlowski, Dr Noopur Raje and Dr Paul G Richardson, moderated by Dr Lonial, including the following topics: Introduction (0:00) Management of Newly Diagnosed Multiple Myeloma (MM) — Dr Orlowski (1:26) Integration of Novel Therapies into the Management of Relapsed/Refracto…
…
continue reading
1
Chronic Lymphocytic Leukemia | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Chronic Lymphocytic Leukemia
1:57:07
1:57:07
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
1:57:07
Featuring perspectives from Dr Farrukh T Awan, Dr Bita Fakhri, Dr Kerry A Rogers and Dr William G Wierda, moderated by Dr Jeff Sharman, including the following topics: Introduction (0:00) Optimizing First-Line Therapy for Chronic Lymphocytic Leukemia (CLL) — Jeff Sharman, MD (1:44) Emerging Role of Bruton Tyrosine Kinase (BTK) Inhibitors in Combina…
…
continue reading
1
Colorectal and Gastroesophageal Cancers | Cases from the Community: Integrating New Research Findings into Practice
49:11
49:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
49:11
Featuring perspectives from Dr Christopher Lieu, moderated by Dr Stephen “Fred” Divers CME information and select publicationsبقلم Dr. Neil Love
…
continue reading
1
Hepatobiliary Cancers | Cases from the Community: Integrating New Research Findings into Practice
55:50
55:50
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
55:50
Featuring perspectives from Dr Daneng Li, moderated by Dr Stephen “Fred” Divers CME information and select publicationsبقلم Dr. Neil Love
…
continue reading
1
Gynecologic Cancers | Cases from the Community: Integrating New Research Findings into Practice
46:42
46:42
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
46:42
Featuring perspectives from Dr Kathleen N Moore, moderated by Dr Stephen “Fred” Divers CME information and select publicationsبقلم Dr. Neil Love
…
continue reading
1
Myelofibrosis | Cases from the Community: Integrating New Research Findings into Practice
51:44
51:44
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
51:44
Featuring perspectives from Dr Stephen T Oh, moderated by Dr Stephen “Fred” Divers CME information and select publicationsبقلم Dr. Neil Love
…
continue reading
1
ER-Positive Metastatic Breast Cancer | 5-Minute Journal Club: Reviewing the Role of Oral SERDs in the Management of ER-Positive Metastatic Breast Cancer — Issue 2
11:59
11:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
11:59
Featuring an interview with Dr Seth Wander, including the following topics: Design of SERENA-6, a Phase III switching trial of camizestrant for ESR1-mutant breast cancer during first-line treatment Turner N et al. Design of SERENA-6, a phase III switching trial of camizestrant in ESR1-mutant breast cancer during first-line treatment. Future Oncol 2…
…
continue reading
1
Leukemia and Myelodysplastic Syndromes | Cases from the Community: Integrating New Research Findings into Practice
51:45
51:45
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب
51:45
Featuring perspectives from Dr Harry Paul Erba, moderated by Dr Stephen “Fred” Divers CME information and select publicationsبقلم Dr. Neil Love
…
continue reading